Search research articles
Contact Us
Filters
Showing results (201-210 of 339) with videos related to
Page
of 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial
Anthony Howell, John F R Robertson, Paul Abram, et al.
International Journal of Cancer
|
August 30, 2021
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
D Gareth Evans, Elke M van Veen, Helen Byers, et al.
Cell Cycle (Georgetown, Tex.)
|
June 12, 2012
CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth
Claudia Capparelli, Diana Whitaker-Menezes, Carmela Guido, et al.
British Journal of Cancer
|
February 25, 2023
Randomised controlled trial of breast cancer and multiple disease prevention weight loss programmes vs written advice amongst women attending a breast cancer family history clinic
Michelle Harvie, David P French, Mary Pegington, et al.
Cell Cycle (Georgetown, Tex.)
|
October 11, 2012
The milk protein α-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis
Gloria Bonuccelli, Remedios Castello-Cros, Franco Capozza, et al.
Cancer Biology & Therapy
|
November 2, 2011
Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells
Ubaldo E Martinez-Outschoorn, Allison Goldberg, Zhao Lin, et al.
International Journal of Cancer
|
May 2, 2007
Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status
Pal Moller, D Gareth Evans, Marta M Reis, et al.
Journal of Medical Genetics
|
December 20, 2023
Germline testing of <i>BRCA1</i>, <i>BRCA2</i>, <i>PALB2</i> and <i>CHEK2</i> c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of <i>ATM</i>, <i>RAD51C</i> and <i>RAD51D</i> in over 400
Emma R Woodward, Fiona Lalloo, Claire Forde, et al.
The Lancet. Oncology
|
March 29, 2011
Preventive therapy for breast cancer: a consensus statement
Jack Cuzick, Andrea DeCensi, Banu Arun, et al.
Antioxidants & Redox Signaling
|
September 3, 2011
Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis
Stephanos Pavlides, Iset Vera, Ricardo Gandara, et al.
Page
of 34
Search research articles
Search
Showing results (201-210 of 339) with videos related to
Sort By:
Page
of 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial
Anthony Howell, John F R Robertson, Paul Abram, et al.
International Journal of Cancer
|
August 30, 2021
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
D Gareth Evans, Elke M van Veen, Helen Byers, et al.
Cell Cycle (Georgetown, Tex.)
|
June 12, 2012
CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth
Claudia Capparelli, Diana Whitaker-Menezes, Carmela Guido, et al.
British Journal of Cancer
|
February 25, 2023
Randomised controlled trial of breast cancer and multiple disease prevention weight loss programmes vs written advice amongst women attending a breast cancer family history clinic
Michelle Harvie, David P French, Mary Pegington, et al.
Cell Cycle (Georgetown, Tex.)
|
October 11, 2012
The milk protein α-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis
Gloria Bonuccelli, Remedios Castello-Cros, Franco Capozza, et al.
Cancer Biology & Therapy
|
November 2, 2011
Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells
Ubaldo E Martinez-Outschoorn, Allison Goldberg, Zhao Lin, et al.
International Journal of Cancer
|
May 2, 2007
Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status
Pal Moller, D Gareth Evans, Marta M Reis, et al.
Journal of Medical Genetics
|
December 20, 2023
Germline testing of <i>BRCA1</i>, <i>BRCA2</i>, <i>PALB2</i> and <i>CHEK2</i> c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of <i>ATM</i>, <i>RAD51C</i> and <i>RAD51D</i> in over 400
Emma R Woodward, Fiona Lalloo, Claire Forde, et al.
The Lancet. Oncology
|
March 29, 2011
Preventive therapy for breast cancer: a consensus statement
Jack Cuzick, Andrea DeCensi, Banu Arun, et al.
Antioxidants & Redox Signaling
|
September 3, 2011
Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis
Stephanos Pavlides, Iset Vera, Ricardo Gandara, et al.
Page
of 34